Access to innovative cancer medicines in a middle-income country - the case of Mexico.

Moye-Holz, Daniela; Soria Saucedo, Rene; van Dijk, Jitse P; Reijneveld, Sijmen A; Hogerzeil, Hans V

Moye-Holz, Daniela; Soria Saucedo, Rene; van Dijk, Jitse P; Reijneveld, Sijmen A; Hogerzeil, Hans V.

Afiliación

Moye-Holz D; 1Department of Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Soria Saucedo R; 2Boston University School of Public Health, Boston, USA.
van Dijk JP; 1Department of Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Reijneveld SA; 1Department of Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Hogerzeil HV; 1Department of Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

J Pharm Policy Pract ; 11: 25, 2018.

Article en En | MEDLINE | ID: mdl-30386627

Palabras clave

Access; Drug utilization; Essential cancer medicines; Insurance schemes access; Mexico; Regional access

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE País/Región como asunto: Mexico Idioma: En Revista: J Pharm Policy Pract Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google